Chief Medical Officer

Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025

Spyre Therapeutics announces poster presentations at UEGW 2025

Spyre Therapeutics initiated with bullish view at Deutsche Bank, here's why

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Manager, Translational Operations

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation products for inflammatory bowel disease and other immune-mediated diseases. They are seeking a highly organized Manager of Translational Operations to oversee biosample strategies and implementation for global clinical trials, ensuring the integrity and timely delivery of biospecimens. The role involves collaboration with various teams to optimize clinical trial sample management and data utilization.

Sign up with Google

Sign in with Google